May 24, 2017

Government agency accepted Biologics License Application to extend Opdivo’s use to patients with hepatocellular carcinoma after prior sorafenib therapy.

May 24, 2017

Under the law, which was signed by President Barack Obama in December 2016, the payment structure for infusion drugs under Medicare Part B changed from an average wholesale price to an average sales price.

May 23, 2017

According to the agency, this is the first time it has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated.

May 23, 2017

“Pharmacists need to understand what’s happening around them regarding the availability of precision medicines and their profiles,” Murray Aitken, executive director of the Quintiles IMS Institute and co-author of the report, said during the International Pharmaceutical Federation 6th Pharmaceutical Sciences World Congress.

May 22, 2017

Hoffman La Roche’s drug takes aim at the form of vasculitis, a group of disorders that results in inflammation of blood vessels.

May 19, 2017

The oral therapy is administered twice daily for adults with an FLT3 mutation-positive acute myeloid leukemia diagnosis.

May 17, 2017

The company’s doxorubicin hydrochloride liposome injection is a sterile, translucent, red liposomal dispersion in 10-mL or 30-mL glass, single-dose vials.

May 17, 2017

According to the FDA, the expanded approval of Kalydeco triples the number of rare gene mutations that the drug can now treat, expanding the indication from the treatment of 10 mutations, to 33.

May 17, 2017

During an analyst meeting, the company also said it will share its plans to continue driving sustainable growth by leveraging its strong portfolio of core blockbuster products, the “industry-leading” productivity of its innovation model, and the pending acquisition of Swiss-based biotech company Actelion.

May 17, 2017

Cliff Osbon talks about how the independent specialty pharmacy differentiates itself from the competition so much that was named to Inc. Magazine’s top growth list five times. 

May 16, 2017

SB-525 uses a recombinant adeno-associated virus to deliver a human Factor VIII cDNA construct and proprietary, synthetic liver-specific promoter to the nucleus of liver cells with a single infusion.

May 16, 2017

Clofarabine injection is a purine nucleoside metabolic inhibitor indicated for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens.

May 12, 2017

The NCPA letter to Republican Seantors cites research that a leading predictor of adherence is a patient’s proximity to and relationship with a pharmacist.

May 11, 2017

This second term of accreditation falls under URAC’s Specialty Pharmacy 3.0 standards.

May 10, 2017

Bavencio (avelumab) Injection is intended for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, or who have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.

May 9, 2017
WRB will join Envoy Health Management as part of Diplomat’s offering of commercialization support services for manufacturers and biotech firms, among other service companies.
 
May 8, 2017

Executives from Celgene, Regeneron and Vertex represented the drug industry Monday during a biomedical research discussion, but drug prices, long a concern of President Donald Trump, were not discussed during the two-hour meeting.

May 8, 2017

Research of Mitsubishi Tanabe America drug showed individuals receiving edaravone declined less on a clinical assessment of daily functioning compared to those receiving a placebo.

May 5, 2017

The clinical-stage biopharmaceutical company listed 9.9 million shares at $17 per share on May 4. 

May 5, 2017

This announcement represents a major “step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries,” the organization stated.

May 4, 2017

Total sales decline by 3% year over, but comparable-store stores improve by 1.2% year over year.

May 1, 2017
AmerisourceBergen said that 2016 revenue contribution from its existing agreement with Express Scripts was roughly $23 billion.
 
April 27, 2017

BioMarin Pharmaceuticals’ Brineura slows loss of walking ability (ambulation) in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.

April 27, 2017

The drug, manufactured by Bayer HealthCare Pharmaceuticals, is the first FDA-approved treatment for a liver cancer in almost a decade.